腸内からの高密度リポプロテインは,ポータル静脈経由で肝臓の損傷を抑制する
Yong-Hyun Han1,2, Emily J Onufer3, Li-Hao Huang4
1Department of Pathology, Washington University School of Medicine, St. Louis, MO 63110, USA. gjrandolph@wustl.edu yhhan1015@kangwon.ac.kr.
まとめ
腸産高密度リポタンパク質 (HDL) は,リポポリサッカリド (LPS) を中和することによって,肝臓を損傷から保護する. 腸内HDLを増加させる治療は 腸内外傷の後の肝臓の結果を改善します
科学分野:
- 心血管生物学
- ヘパトロジー
- 免疫学
背景:
- 高密度リポプロテイン (HDL) のバイオゲネシスには,アポリポプロテインA1 (apoA1) とABCA1が含まれています.
- 肝臓はHDLの主要生産部ですが,小腸もHDLを合成しています.
- 腸内リポポリサッカリド (LPS) は肝炎や損傷を引き起こす可能性があります.
研究 の 目的:
- 肝臓の保護における腸由来HDLの役割と機能を調査する.
- LPSによる肝損傷に対する腸内HDLの保護機構を決定する.
主な方法:
- 腸由来のHDL亜種 (HDL3) とその複合体とリポポリサカリド結合タンパク質 (LBP) の特徴
- HDL亜種がLPS結合と肝臓マクロファージの炎症活性化を防ぐ能力の評価
- 肝臓損傷のマウスモデルにおける腸内HDL増加を目的とした治療戦略の評価
主要な成果:
- 腸に由来するHDL,特にHDL3亜種は,LBPと複合体を形成し,ポータル静脈を通過します.
- HDL3は,HDL2またはLDLとは異なり,肝臓マクロファージへのLPS結合を効果的に防止し,細胞外LPS不活性化を支援しました.
- 腸に由来するHDLの喪失が肝臓損傷を悪化させた.
- 腸内HDLレベルを上昇させた治療薬は,これらの肝臓損傷モデルでの結果を改善しました.
結論:
- 腸に由来するHDLは,腸に由来するLPSによる損傷から肝臓を保護する上で重要な役割を果たします.
- HDL3は,LPSを中和し,肝炎を緩和する重要な亜種です.
- 腸内HDL合成の強化は,腸由来LPSに関連した肝疾患の潜在的な治療戦略です.
関連する概念動画
Hepatic Portal System
3.0K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
3.0K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
34
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
34
Cholesterol: Significance and Regulation
773
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
773
Liver Regeneration
3.5K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
986
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
986
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
36
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
36


